Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease

Pathology International
Reisuke H TakahashiGunnar K Gouras


Amyloid plaques and neurofibrillary tangles (NFTs) in the brain are the neuropathological hallmarks of Alzheimer's disease (AD). Amyloid plaques are composed of β-amyloid peptides (Aβ), while NFTs contain hyperphosphorylated tau proteins. Patients with familial AD who have mutations in the amyloid precursor protein (APP) gene have either increased production of Aβ or generate more aggregation-prone forms of Aβ. The findings of familial AD mutations in the APP gene suggest that Aβ plays a central role in the pathophysiology of AD. Aβ42, composed of 42 amino acid residues, aggregates readily and is considered to form amyloid plaque. However, the processes of plaque formation are still not well known. It is generally thought that Aβ is secreted into the extracellular space and aggregates to form amyloid plaques. Aβ as extracellular aggregates and amyloid plaques are thought to be toxic to the surrounding neurons. The intraneuronal accumulation of Aβ has more recently been demonstrated and is reported to be involved in synaptic dysfunction, cognitive impairment, and the formation of amyloid plaques in AD. We herein provide an overview of the process of the intraneuronal accumulation of Aβ and plaque formation, and discuss its impli...Continue Reading


Feb 18, 1989·Lancet·Alison M GoateR Williamson
Aug 1, 1988·Journal of Neurochemistry·F PrelliB Frangione
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Sep 1, 1993·Journal of Neuroscience Research·R G Parton, C G Dotti
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A M WertkinV M Lee
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·H XuS Gandy
Aug 14, 1999·Journal of Neuropathology and Experimental Neurology·C A WilsonV M Lee
Jan 7, 2000·The American Journal of Pathology·Gunnar K GourasN R Relkin
Feb 1, 2000·European Archives of Psychiatry and Clinical Neuroscience·T Hartmann
Nov 5, 2002·The American Journal of Pathology·Reisuke H TakahashiGunnar K Gouras
Nov 26, 2003·Experimental Neurology·Véronique BlanchardLaurent Pradier
Apr 9, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Reisuke H TakahashiGunnar K Gouras
Apr 9, 2004·Nature Reviews. Molecular Cell Biology·Jean Gruenberg, Harald Stenmark
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chi-Cheng WuFloyd E Bloom
Sep 29, 2004·Neuron·Dominic M Walsh, Dennis J Selkoe
Oct 12, 2004·Journal of Neurocytology·Donna L MoolmanMichael L Shelanski
Jul 19, 2005·Neurobiology of Aging·Gunnar K GourasReisuke H Takahashi
Apr 21, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Claudia G AlmeidaGunnar K Gouras
Sep 23, 2006·Science·Melanie Meyer-LuehmannMathias Jucker
May 18, 2007·Annual Review of Cell and Developmental Biology·Robert C Piper, David J Katzmann
Sep 6, 2008·Neurobiology of Aging·Reisuke H TakahashiGunnar K Gouras
Feb 3, 2009·Acta Neuropathologica·Khalid IqbalInge Grundke-Iqbal
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ralf P FriedrichMarcus Fändrich
Feb 13, 2010·The FEBS Journal·Masafumi Sakono, Tamotsu Zako
Sep 20, 2011·The American Journal of Pathology·Estibaliz Capetillo-ZarateGunnar K Gouras
Jul 24, 2012·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Hideaki KaiTetsuyuki Kitamoto
Jan 4, 2013·The Journal of Biological Chemistry·Javier Pacheco-Quinto, Elizabeth A Eckman
Jul 6, 2014·Neuron·Celeste M KarchAlison M Goate
Mar 4, 2015·Brain : a Journal of Neurology·Alaina Baker-NighChangiz Geula


Nov 24, 2017·International Journal of Molecular Sciences·Agnese GugliandoloEmanuela Mazzon
Oct 11, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Botond PenkeLívia Fülöp
Aug 3, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jong Kil Lee, Nam-Jung Kim
May 8, 2018·Nutrients·Yan Yan JinSeong-Tschool Hong
Jan 20, 2018·International Journal of Alzheimer's Disease·Stefany MontufarRosario Paredes
Nov 4, 2017·CNS Drugs·Ana B Ramos-HrybAna Lúcia S Rodrigues
Oct 27, 2018·Acta Neuropathologica·Lindsay A WelikovitchA Claudio Cuello
Jan 5, 2018·Acta Neuropathologica Communications·Maria Luisa MoroDelphine Boche
Sep 13, 2018·Current Neuropharmacology·Muneeb U RehmanRehan Khan
Jan 11, 2019·Journal of Neuropathology and Experimental Neurology·Alessandro GiulianiLuciana Giardino
Dec 27, 2017·Current Medicinal Chemistry·Antoni SuredaSilvia Tejada
Nov 22, 2019·The FEBS Journal·Amanda B ChaiIngrid C Gelissen
Dec 18, 2019·The Cochrane Database of Systematic Reviews·Lucy C BeishonVictoria J Haunton
Jan 7, 2020·The International Journal of Neuroscience·Min ShiHongfu Li
Jun 4, 2020·Phytotherapy Research : PTR·Milad AshrafizadehKwang Seok Ahn
Nov 9, 2017·International Journal of Molecular Medicine·Cheng GaoLuyang Tao
Aug 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia HiltJohn C Voss
Apr 21, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Spyridon MourtasSophia G Antimisiaris
Jan 24, 2020·Frontiers in Aging Neuroscience·RuiJuan ChenYi Zeng
Mar 21, 2020·Advanced Science·Oxana KlementievaFerenc Borondics
Apr 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Botond PenkeFerenc Bogár
Mar 22, 2018·Frontiers in Aging Neuroscience·Steven A Harris, Elizabeth A Harris
Mar 2, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Saak V OvsepianJ Oliver Dolly
Feb 6, 2019·Scientific Reports·Tamás LetohaLászló Szilák
Mar 24, 2020·Environmental Science and Pollution Research International·Md Ataur RahmanHyewhon Rhim
Apr 29, 2018·Cellular and Molecular Life Sciences : CMLS·Cláudia Guimas AlmeidaTatiana Burrinha
Aug 14, 2019·International Journal of Molecular Sciences·Marta RusekStanisław J Czuczwar
Nov 14, 2019·Critical Care : the Official Journal of the Critical Care Forum·Cina SasannejadShouri Lahiri
Apr 9, 2020·Frontiers in Pharmacology·Nurul Husna IbrahimJaya Kumar
Jun 5, 2020·Science Advances·Dana M CairnsDavid L Kaplan
Jul 7, 2018·Analytical and Bioanalytical Chemistry·Maria Elvira CarboneAnna Maria Salvi
Apr 11, 2019·Molecular Neurobiology·Geir BjørklundSalvatore Chirumbolo
May 5, 2020·Frontiers in Cellular Neuroscience·Catarina PerdigãoCláudia Guimas Almeida
Nov 28, 2019·Journal of Alzheimer's Disease : JAD·Gregory J BrewerCharles G Glabe
Jun 18, 2020·Scientific Reports·Masahiro KuraganoKiyotaka Tokuraku
Oct 8, 2020·Cell Death & Disease·Ling HuangAntonio Currais
Jan 28, 2021·Archives of Virology·Jéssica WoukLigia Carla Faccin-Galhardi
Jan 6, 2021·Communications Biology·Rodrigo CataldiMichele Vendruscolo
Dec 23, 2020·International Journal of Molecular Sciences·Giulia GagnoAneta Aleksova
Dec 14, 2017·Neuropharmacology·Elizabeth G Mietlicki-Baase
Dec 24, 2020·International Journal of Molecular Sciences·Stephanie Cristine Hepp RehfeldtStefan Laufer
Mar 22, 2021·Molecular Neurobiology·Nashmin FayaziRezvan Najafi
Feb 23, 2019·European Journal of Pharmacology·Morgan A AlfordAndis Klegeris
May 1, 2021·International Journal of Molecular Sciences·Stephanie Cristine Hepp RehfeldtMárcia Inês Goettert
Dec 15, 2019·Bioorganic & Medicinal Chemistry Letters·Shuang-Jun LiZhi-Jian Zhang
May 26, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Yingying ZhaoQinghua Wu

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

Histology and Histopathology
Reisuke H TakahashiGunnar K Gouras
Progress in Molecular Biology and Translational Science
Steven P BraithwaiteAngus C Nairn
© 2021 Meta ULC. All rights reserved